Longitude Venture Partners L.P.'s Net Worth

$365 Million

Estimate Recalculated Dec 4, 2025 01:11AM EST

Who is Longitude Venture Partners L.P.

Longitude Venture Partners L.P. has an estimated net worth of $365 Million. This is based on reported shares across multiple companies, which include CORCEPT THERAPEUTICS INC, COLLEGIUM PHARMACEUTICAL, INC, and Esperion Therapeutics, Inc..

SEC CIK

Longitude Venture Partners L.P.'s CIK is 0001419701

Past Insider Trading and Trends

2009 was Longitude Venture Partners L.P.'s most active year for acquiring shares with 4 total transactions. Longitude Venture Partners L.P.'s most active month to acquire stocks was the month of February. 2014 was Longitude Venture Partners L.P.'s most active year for disposing of shares, totalling 12 transactions. Longitude Venture Partners L.P.'s most active month to dispose stocks was the month of February. 2015 saw Longitude Venture Partners L.P. paying a total of $9,638,354.91 for 3,091,479 shares, this is the most they've acquired in one year. In 2015 Longitude Venture Partners L.P. cashed out on 4,176,607 shares for a total of $6,237,129.20, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

COLLEGIUM PHARMACEUTICAL, INC

Investor
Updated Dec 12, 2017
Form 4
-30.10%
-1.00M
$17.34
-$17.34M
Dec 12, 2017
2.32M
Sale
Dec 08
Form 4
-84.53%
-18.14M
$12.00
May 14, 2015
3.32M
Buy-Options
May 12
Form 3
May 08, 2015
Showing 3 results

CORCEPT THERAPEUTICS INC

Investor
Updated Nov 30, 2016
Form 4
-21.50%
-3.00M
Nov 30, 2016
10.96M
Disposition
Nov 28
Form 4
-0.26%
-36.94K
$9.34
-$345.17K
Nov 25, 2016
13.96M
Sale
Nov 22 - Nov 25
Form 4
-3.74%
-544.10K
$9.56
-$5.20M
Nov 21, 2016
13.99M
Sale
Nov 17 - Nov 21
Form 4
-1.19%
-174.85K
$9.55
-$1.67M
Nov 17, 2016
14.54M
Sale
Nov 15 - Nov 16
Form 4
$4.05
$3.47M
Apr 01, 2015
14.71M
Options
Mar 30
Form 4
-6.78%
-1.09M
$4.29
-$10.79
Mar 24, 2015
14.99M
Sale
Mar 20 - Mar 24
Form 4
-0.97%
-250.00K
$4.10
-$1.03M
May 05, 2014
25.45M
Sale
May 01 - May 02
Form 4
-1.90%
-250.00K
$4.28
-$1.07M
Apr 03, 2014
12.93M
Sale
Apr 01
Form 4
-0.63%
-250.00K
$4.00
-$1.00M
Mar 07, 2014
39.74M
Sale
Mar 05 - Mar 07
Form 4
6.38%
856.64K
$1.55
$2.54M
Apr 02, 2012
14.29M
Purchase
Mar 29
Form 4
6.34%
750.00K
$3.90
$2.93M
Jan 25, 2011
12.58M
Purchase
Jan 21
Form 4
7.24%
856.64K
$0.90
$1.42M
Apr 23, 2010
12.68M
Purchase
Apr 21
Form 4
38.77%
3.30M
$0.75
$3.48M
Oct 19, 2009
11.83M
Purchase
Oct 16
Form 4
91.04%
5.14M
$0.41
$3.25M
Feb 10, 2009
10.78M
Purchase
Feb 06
Form 4
9.90%
349.43K
$1.45
$506.67K
Nov 13, 2008
3.88M
Grant
Nov 11
Form 3
Apr 04, 2008
3.53M
Showing 16 results

Esperion Therapeutics, Inc.

Investor
Updated Nov 19, 2014
Form 4
-25.35%
-487.13K
$32.78
-$15.97M
Nov 19, 2014
1.43M
Sale
Nov 17 - Nov 18
Form 4
-0.05%
-943.00
$30.00
-$28.29K
Oct 14, 2014
1.92M
Sale
Oct 09
Form 4
-0.62%
-11.93K
$30.04
-$358.29K
Oct 09, 2014
1.92M
Sale
Oct 07
Form 4
12.61%
216.68K
$14.00
Jul 01, 2013
1.93M
Purchase
Jul 01
Form 3
Jun 25, 2013
Showing 5 results